Geographic Variation In Effective Contraceptive Use Among Medicaid Recipients In 2018

被引:5
作者
Rodriguez, Maria I. [1 ]
Meath, Thomas H. A. [1 ]
Watson, Kelsey [1 ]
Daly, Ashley [1 ]
Tracy, Kyle [1 ]
McConnell, K. John [1 ]
机构
[1] Oregon Hlth & Sci Univ, Portland, OR 97239 USA
关键词
UNITED-STATES; UNINTENDED PREGNANCY; SOCIAL DETERMINANTS; TITLE X; HEALTH; EPIDEMIOLOGY; ASSOCIATION;
D O I
10.1377/hlthaff.2022.00992
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Medicaid is the largest payer for publicly funded contraception, serving millions of women across the United States. However, relatively little is known about the extent to which effective contraceptive services vary geographically for Medicaid recipients. This study used national Medicaid claims to assess county-level variation in rates of provision of the most or moderately effective methods of contraception and provision of long-acting reversible contraception (LARC) across forty states and Washington, D.C., in 2018. County-level rates of most or moderately effective contraceptive use varied almost fourfold across states, from a low of 10.8 percent to a high of 44.4 percent. Rates of LARC provision varied almost tenfold, from a low of 1.0 percent to a high of 9.6 percent. Despite the fact that contraception is a core benefit within Medicaid, access and use vary substantially across and within states. Medicaid agencies have a variety of options to ensure that people have access to a choice of the full range of contraceptive methods, including removing or loosening utilization controls, incorporating quality metrics or value -based payments into contraceptive services, and adjusting reimbursement to remove barriers to the clinical provision of LARC.
引用
收藏
页码:537 / 545
页数:9
相关论文
共 49 条
  • [1] ACOG Committee Opinion No. 729: Importance of Social Determinants of Health and Cultural Awareness in the Delivery of Reproductive Health Care
    Ades, Veronica
    Goddard, Brian
    Ayala, Savannah Pearson
    Bach, Sonya Chemouni
    Wu, Stephanie X.
    [J]. OBSTETRICS AND GYNECOLOGY, 2018, 131 (06) : 1162 - 1163
  • [2] American College of Obstetricians and Gynecologists, 2021, MED REIMB POSTP LARC
  • [3] Drospirenone (Slynd)-A New Progestin-Only Oral Contraceptive (Reprinted from JAMA, vol 62, pg 18-19, 2020)
    不详
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (19): : 1963 - 1964
  • [4] [Anonymous], 2015, Obstet Gynecol, V125, P250, DOI 10.1097/01.AOG.0000459866.14114.33
  • [5] [Anonymous], 2014, Obstet Gynecol, V123, P384, DOI 10.1097/01.AOG.0000443278.06393.d6
  • [6] [Anonymous], 2014, EFF CONTR US WOM RIS
  • [7] Research on neighborhood effects on health in the United States: A systematic review of study characteristics
    Arcaya, Mariana C.
    Tucker-Seeley, Reginald D.
    Kim, Rockli
    Schnake-Mahl, Alina
    So, Marvin
    Subramanian, S. V.
    [J]. SOCIAL SCIENCE & MEDICINE, 2016, 168 : 16 - 29
  • [8] Women's Reproductive Coercion and Pregnancy Avoidance: Associations With Homicide Risk, Sexual Violence, and Religious Abuse
    Bagwell-Gray, Meredith E.
    Thaller, Jonel
    Messing, Jill T.
    Durfee, Alesha
    [J]. VIOLENCE AGAINST WOMEN, 2021, 27 (12-13) : 2294 - 2312
  • [9] Brooks T., 2020, Medicaid and chip eligibility, enrollment, and cost sharing policies as of january 2019: findings from a 50-state survey
  • [10] Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P241